Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsThe authors discuss the role of epithelial‐mesenchymal transition of breast cancer stem cells (BCSCs) in the setting of trastuzumab resistance and approaches of reducing or eradicating BCSCs in HER2‐positive breast cancer.
[Stem Cells]
6807162 R3KP64G7 items 1 apa 0 default asc 1 161181 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-0365a0d506471d6d609cc67d92b9f79d%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22R3KP64G7%22%2C%22library%22%3A%7B%22id%22%3A6807162%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Qiu%20et%20al.%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EQiu%2C%20Y.%2C%20Yang%2C%20L.%2C%20Liu%2C%20H.%2C%20%26amp%3B%20Luo%2C%20X.%20%28n.d.%29.%20Cancer%20Stem%20Cell-Targeted%20Therapeutic%20Approaches%20for%20Overcoming%20Trastuzumab%20Resistance%20in%20HER2-Positive%20Breast%20Cancer.%20%3Ci%3ESTEM%20CELLS%3C%5C%2Fi%3E%2C%20%3Ci%3En%5C%2Fa%3C%5C%2Fi%3E%28n%5C%2Fa%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2Fhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fstem.3381%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2Fhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fstem.3381%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6807162%26amp%3Bitem_key%3DR3KP64G7%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cancer%20Stem%20Cell-Targeted%20Therapeutic%20Approaches%20for%20Overcoming%20Trastuzumab%20Resistance%20in%20HER2-Positive%20Breast%20Cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yan%22%2C%22lastName%22%3A%22Qiu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Libo%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Honghong%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaobo%22%2C%22lastName%22%3A%22Luo%22%7D%5D%2C%22abstractNote%22%3A%22Application%20of%20the%20anti-HER2%20drug%20trastuzumab%20has%20significantly%20improved%20the%20prognosis%20of%20patients%20with%20the%20HER2-positive%20subtype%20of%20breast%20cancer.%20However%2C%2050%25%20of%20patients%20with%20HER2%20amplification%20relapse%20due%20to%20trastuzumab%20resistance.%20Accumulating%20evidence%20indicates%20that%20breast%20cancer%20is%20driven%20by%20a%20small%20subset%20of%20cancer-initiating%20cells%20or%20breast%20cancer%20stem%20cells%20%28BCSCs%29%2C%20which%20have%20the%20capacity%20to%20self-renew%20and%20differentiate%20to%20regenerate%20the%20tumor%20cell%20hierarchy.%20Increasing%20data%20suggest%20that%20BCSCs%20are%20resistant%20to%20conventional%20therapy%2C%20including%20chemotherapy%2C%20radiotherapy%2C%20and%20endocrine%20therapy%2C%20which%20drives%20distant%20metastasis%20and%20breast%20cancer%20relapse.%20In%20recent%20years%2C%20the%20trastuzumab%20resistance%20of%20breast%20cancer%20has%20been%20closely%20related%20to%20the%20prevalence%20of%20BCSCs.%20Here%2C%20our%20primary%20focus%20is%20to%20discuss%20the%20role%20of%20epithelial-mesenchymal%20transition%20%28EMT%29%20of%20BCSCs%20in%20the%20setting%20of%20trastuzumab%20resistance%20and%20approaches%20of%20reducing%20or%20eradicating%20BCSCs%20in%20HER2-positive%20breast%20cancer.%20%5Cu00a9%20AlphaMed%20Press%202021%20Significance%20Statement%20In%20HER2-positive%20breast%20tumors%2C%20trastuzumab%20target%20therapy%20has%20shown%20efficacy%20in%20removing%20non-BCSCs%20while%20failed%20to%20eradicate%20partial%20BCSCs.%20Targeting%20BCSCs%20might%20be%20a%20promising%20approach%20to%20prevent%20distant%20metastasis%20and%20local%20recurrence%20of%20HER2-positive%20breast%20cancer.%20Herein%2C%20we%20aim%20to%20discuss%20the%20mechanism%20of%20trastuzumab%20resistance%20in%20BCSCs%20of%20HER2-positive%20cancer%20cells%20and%20the%20approaches%20of%20reducing%20or%20eradicating%20BCSCs%2C%20especially%20after%20anti-HER2%20therapy.%22%2C%22date%22%3A%22%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fstem.3381%22%2C%22ISSN%22%3A%221549-4918%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fstemcellsjournals.onlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1002%5C%2Fstem.3381%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-04-14T20%3A45%3A52Z%22%7D%7D%5D%7D
Qiu, Y., Yang, L., Liu, H., & Luo, X. (n.d.). Cancer Stem Cell-Targeted Therapeutic Approaches for Overcoming Trastuzumab Resistance in HER2-Positive Breast Cancer. STEM CELLS, n/a(n/a). https://doi.org/https://doi.org/10.1002/stem.3381 Cite
